February 6, 2018
Poxel CEO Thomas Kuhn French biopharma Poxel is looking at Japan as the world’s first market to debut its lead diabetes drug candidate imeglimin as it hopes to capitalize on its collaboration with local partner Sumitomo Dainippon Pharma, CEO Thomas...read more